Innovative demand creation strategies to increase voluntary medical male circumcision uptake: a pragmatic randomised controlled trial in Zimbabwe. 2021

Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
Centre for Sexual Health and HIV/AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe webster@ceshhar.co.zw.

Reaching men aged 20-35 years, the group at greatest risk of HIV, with voluntary medical male circumcision (VMMC) remains a challenge. We assessed the impact of two VMMC demand creation approaches targeting this age group in a randomised controlled trial (RCT). We conducted a 2×2 factorial RCT comparing arms with and without two interventions: (1) standard demand creation augmented by human-centred design (HCD)-informed approach; (2) standard demand creation plus offer of HIV self-testing (HIVST). Interpersonal communication (IPC) agents were the unit of randomisation. We observed implementation of demand creation over 6 months (1 May to 31 October 2018), with number of men circumcised assessed over 7 months. The primary outcome was the number of men circumcised per IPC agent using the as-treated population of actual number of months each IPC agent worked. We conducted a mixed-methods process evaluation within the RCT. We randomised 140 IPC agents, 35 in each arm. 132/140 (94.3%) attended study training and 105/132 (79.5%) reached at least one client during the trial period and were included in final analysis. There was no evidence that the HCD-informed intervention increased VMMC uptake versus no HCD-informed intervention (incident rate ratio (IRR) 0.87, 95% CI 0.38 to 2.02; p=0.75). Nor did offering men a HIVST kit at time of VMMC mobilisation (IRR 0.65, 95% CI 0.28 to 1.50; p=0.31). Among IPC agents that reported reaching at least one man with demand creation, both the HCD-informed intervention and HIVST were deemed useful. There were some challenges with trial implementation; <50% of IPC agents converted any men to VMMC, which undermined our ability to show an effect of demand creation and may reflect acceptability and feasibility of the interventions. This RCT did not show evidence of an effect of HCD-informed demand intervention or HIVST on VMMC uptake. Findings will inform future design and implementation of demand creation evaluations. PACTR201804003064160.

UI MeSH Term Description Entries

Related Publications

Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
July 2021, BMJ global health,
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
October 2016, Journal of acquired immune deficiency syndromes (1999),
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
August 2016, Journal of acquired immune deficiency syndromes (1999),
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
July 2018, Journal of acquired immune deficiency syndromes (1999),
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
January 2014, The Pan African medical journal,
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
August 2016, Journal of acquired immune deficiency syndromes (1999),
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
May 2015, The lancet. HIV,
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
August 2016, Journal of acquired immune deficiency syndromes (1999),
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
August 2016, Journal of acquired immune deficiency syndromes (1999),
Webster Mavhu, and Melissa Neuman, and Karin Hatzold, and Stephen Buzuzi, and Galven Maringwa, and Sungai T Chabata, and Collin Mangenah, and Noah Taruberekera, and Ngonidzashe Madidi, and Malvern Munjoma, and Getrude Ncube, and Sinokuthemba Xaba, and Owen Mugurungi, and Cheryl C Johnson, and Elizabeth L Corbett, and Helen A Weiss, and Katherine Fielding, and Frances M Cowan
January 2015, Global public health,
Copied contents to your clipboard!